DECREASED IL-2 SYNTHESIS IN TYPE I DIABETES
DECREASED IL-2 SYNTHESIS IN TYPE I DIABETES
批准号:
3145569
负责人:
KAREN S ZIER
金额:
$16.0万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-05-01 至 1993-04-30
关键词:
T cell receptor T lymphocyte autoimmune disorder biological signal transduction densitometry gene expression genetic transcription human subject in situ hybridization insulin dependent diabetes mellitus interleukin 2 interleukin 4 interleukin 6 leukocyte activation /transformation messenger RNA molecular pathology protein biosynthesis siblings
中文摘要
免疫系统被设计用来识别外来入侵者并
英文摘要
The immune system is designed to recognize foreign invaders and to
eliminate them from the body. Upon occasion, however, this mechanism can
turn against itself and initiate and attack against shelf components
leading to an autoimmune disease. Insulin dependent diabetes (IDD) is one
autoimmune disease directed against the insulin producing beta cells. The
working hypothesis of this study is that the abnormality in IL-2 levels may
lead to aberrant effector responses mediated by T cells. the long-term
goal of this proposal is to increase knowledge of the immunological
abnormalities associated with IDD by defining the mechanism(s) underlying
one of them, the deficiency in Interleukin-2 (IL-2) synthesis observed in
IDDs. This phenomenon was first reported by us and has subsequently been
confirmed by other investigators. It is one of few immunological defects
affecting T cell function on a non-clonal level. In this resubmission, we
will include non-diabetic, HLA-identical sibs of our patients in the
research plan, in order to study whether any of the abnormalities
associated with this defect may precede the onset of frank disease. The
primary aim of the study is to test the hypothesis that IL-2 defect is
regulated at the level of the expression of the IL-2 gene. In addition, we
will examine whether signalling independent of the T cell receptor results
in normal IL-2 synthesis and whether there are inhibitory lymphokines which
prevent the IL-2 from stimulating T cell growth. The work described,
largely based upon techniques of molecular biology, will build upon our
earlier studies which used exclusively cellular techniques. Recent data
have shown that Cyclosporin A can induce remission in newly diagnosed IDDs.
The demonstration that the autoimmune process can be interrupted makes an
understanding of the pathogenesis of IDD all the more important, since it
may suggest additional therapeutic modalities. The elucidation of the IL-2
defect may lead to the development of such approaches, by precisely
defining the level of control resulting in abnormalities of the cell
medited immune system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ABNORMAL TCR/CD3 SIGNAL TRANSDUCTION IN CANCER
-
批准号:2104722
-
项目类别:
-
资助金额:$19.38万
-
财政年份:1995
-
负责人:KAREN S ZIER
-
依托单位:
ABNORMAL TCR/CD3 SIGNAL TRANSDUCTION IN CANCER
-
批准号:2443072
-
项目类别:
-
资助金额:$20.84万
-
财政年份:1995
-
负责人:KAREN S ZIER
-
依托单位:
ABNORMAL TCR/CD3 SIGNAL TRANSDUCTION IN CANCER
-
批准号:2104723
-
项目类别:
-
资助金额:$20.04万
-
财政年份:1995
-
负责人:KAREN S ZIER
-
依托单位:
DECREASED IL-2 SYNTHESIS IN TYPE I DIABETES
-
批准号:3145570
-
项目类别:
-
资助金额:$16.61万
-
财政年份:1990
-
负责人:KAREN S ZIER
-
依托单位:
DECREASED IL-2 SYNTHESIS IN TYPE I DIABETES
-
批准号:3145571
-
项目类别:
-
资助金额:$17.27万
-
财政年份:1990
-
负责人:KAREN S ZIER
-
依托单位:
CLASS II-IA EXPRESSION BY ACTIVATING T CELLS
-
批准号:3135737
-
项目类别:
-
资助金额:$15.69万
-
财政年份:1988
-
负责人:KAREN S ZIER
-
依托单位:
CLASS II (IA) EXPRESSION BY ACTIVATED T CELLS
-
批准号:3135738
-
项目类别:
-
资助金额:$8.17万
-
财政年份:1988
-
负责人:KAREN S ZIER
-
依托单位:
CLASS II (IA) EXPRESSION BY ACTIVATED T CELLS
-
批准号:3135733
-
项目类别:
-
资助金额:$15.24万
-
财政年份:1986
-
负责人:KAREN S ZIER
-
依托单位:
CLASS II (IA) EXPRESSION BY ACTIVATED T CELLS
-
批准号:3135736
-
项目类别:
-
资助金额:$5.87万
-
财政年份:1986
-
负责人:KAREN S ZIER
-
依托单位:
DETECTION OF HUMAN MINOR ALLOANTIGENS USING CTL LINES
-
批准号:3132297
-
项目类别:
-
资助金额:$12.95万
-
财政年份:1984
-
负责人:KAREN S ZIER
-
依托单位:
DETECTION OF HUMAN MINOR ALLOANTIGENS USING CTL LINES
-
批准号:3132299
-
项目类别:
-
资助金额:$13.5万
-
财政年份:1984
-
负责人:KAREN S ZIER
-
依托单位:
DETECTION OF HUMAN MINOR ALLOANTIGENS USING CTL LINES
-
批准号:3132300
-
项目类别:
-
资助金额:$14.2万
-
财政年份:1984
-
负责人:KAREN S ZIER
-
依托单位:
PILOT--ABNORMAL IMMUNE MECHANISMS IN INSULIN DEPENDENT DIABETICS
-
批准号:4689197
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:KAREN S ZIER
-
依托单位:
INDUCTION OF CLASS II GENE EXPRESSION IN ACTIVATED T CELLS
-
批准号:3954145
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:KAREN S ZIER
-
依托单位:
海外基金